| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 11,056 | 5,553 | 1,815 | | Cost of Revenue | 4,512 | 4,009 | 790 | | | Gross Profit | 6,544 | 1,544 | 1,025 | | | Operating Expenses | | Research Development | 519 | 1,006 | 1,475 | | Selling General and Administrative | 2,325 | 1,980 | 1,619 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 3,700 | (1,442) | (2,068) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (181) | (40) | 296 | | Earnings Before Interest And Taxes | 3,519 | (1,482) | (1,772) | | Interest Expense | 163 | 237 | 1,357 | | Income Before Tax | 3,355 | (1,719) | (3,129) | | Income Tax Expense | 422 |
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 2,934 | (1,719) | (3,129) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 2,934 | (1,719) | (3,129) | | Preferred Stock And Other Adjustments | (130) | (82) | (123) | | | Net Income Applicable To Common Shares | $2,804 | ($1,801) | ($3,252) |
|
0.29% Nasdaq 
Income Statement
